Skip to content

Effect of melatonin on semen parameters and reproductive hormones in men with idiopathic infertility

The effect of melatonin on semen parameters and reproductive hormones in men with idiopathic infertility

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230418057949N1
Enrollment
90
Registered
2023-04-24
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility. Male infertility

Interventions

Intervention 1: Intervention group: They will receive melatonin drug with a dose of 5 mg (obtained from Hakim Pharmaceutical Company), one hour before sleep for 2 months. Intervention 2: Control group

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Men aged 18 to 45 with a history of infertility for at least one year Having a disorder in the spermogram with an unknown cause based on the criteria of the World Health Organization No underlying disease No history of chemotherapy Normality of gonadotropins Testosterone and prolactin Having a BMI less than 30

Exclusion criteria

Exclusion criteria: Azoospermia and the presence of chromosomal disorders such as Kleinfelter Taking chemical drugs during study Taking antioxidant supplements in the last three months Having intense physical activity Taking drugs that stimulate the sexual system or disrupt sex hormones. Genital infections Infectious diseases characterized by fever and leukocytosis. Infertility in wife and abnormal urology examination

Design outcomes

Primary

MeasureTime frame
Improvement of spermogram test. Timepoint: Before the start of the intervention and three months after the treatment. Method of measurement: Semen analysis.

Secondary

MeasureTime frame
Changes in FSH. Timepoint: Before the start of the intervention and three months after the treatment. Method of measurement: Laboratory (hormone measurement, relevant techniques for each test).;Changes in LH. Timepoint: Before the start of the intervention and three months after the treatment. Method of measurement: Laboratory (hormone measurement, relevant techniques for each test).;Changes in testosterone levels. Timepoint: Before the start of the intervention and three months after the treatment. Method of measurement: Laboratory (hormone measurement, relevant techniques for each test).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Akbari

Babol University of Medical Sciences

dr_akbari89@yahoo.com+98 11 1227 4881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026